Resiquimod

• CAS: 144875-48-9
• Catalog Number: ACM144875489
• Category: Inhibitors
• Molecular Weight: 314.387
• Molecular Formula: C₁₇H₂₂N₄O₂
• Description: Resiquimod is a Toll-like receptor 7 and 8 (TLR7/TLR8) agonist that induces the upregulation of cytokines such as TNF-α, IL-6 and IFN-α.
• Synonyms: RESIQUIMOD;1-[4-Amino-2-(ethoxymethyl)-1H-imidazo[4,5-C]quinolin-1-yl]-2-methylpropan-2-ol;Chebi:36706;4-Amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol;4-Amino-2-(ethoxymethyl)-alpha;alpha-dimethyl-1H-imidazo(4,5-c)quinoline-1-ethanol;resquimod;R848,Resiquimod
• Density: 1.28

Custom Q&A

What is the molecular formula of Resiquimod?

The molecular formula of Resiquimod is C17H22N4O2.

What are some synonyms for Resiquimod?

Some synonyms for Resiquimod include R-848 and 1-(4-Amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl)-2-methylpropan-2-ol.

How is Resiquimod being studied in the treatment of skin cancer?

Resiquimod is being studied in the treatment of skin cancer by causing immune cells to produce certain chemicals that may help kill tumor cells when applied to the skin.

What is the molecular weight of Resiquimod?

The molecular weight of Resiquimod is 314.4 g/mol.

How does Resiquimod exert its effect through the TLR signaling pathway?

Resiquimod exerts its effect through the Toll-like receptor (TLR) signaling pathway by binding to and activating TLR7 and 8 on dendritic cells, macrophages, and B-lymphocytes.

What is the IUPAC Name of Resiquimod?

The IUPAC Name of Resiquimod is 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol.

What is the InChIKey of Resiquimod?

The InChIKey of Resiquimod is BXNMTOQRYBFHNZ-UHFFFAOYSA-N.

What is the Canonical SMILES of Resiquimod?

The Canonical SMILES of Resiquimod is CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N.

What is the CAS number of Resiquimod?

The CAS number of Resiquimod is 144875-48-9.

How does Resiquimod enhance the immune response as a vaccine adjuvant?

Resiquimod enhances the immune response as a vaccine adjuvant by activating Langerhans' cells and increasing the production of cytokines, leading to an enhanced activation of T-lymphocytes.